Radioimmunoassay for sulprostone

Area of Science:

• Reproductive endocrinology
• Analytical chemistry
• Pharmacology

Background:

• Sulprostone is a prostaglandin analog used clinically.
• Accurate measurement of sulprostone in biological samples is crucial for pharmacokinetic and pharmacodynamic studies.
• Existing methods may lack the sensitivity or specificity required for subnanogram level detection.

Purpose of the Study:

• To develop and validate a sensitive and specific radioimmunoassay (RIA) for quantifying sulprostone.
• To establish the assay's performance characteristics, including sensitivity, specificity, and precision.
• To apply the developed RIA for measuring sulprostone plasma levels in patients.

Main Methods:

• Development of a sulprostone derivative (9-carboxymethoxime) for conjugation to carrier proteins (keyhole limpet hemocyanin) and radioiodination precursors (tyramine).
• Generation and characterization of a specific antiserum against sulprostone in rabbits.
• Validation of the RIA for sulprostone in plasma, determining assay range, sensitivity, and precision (coefficient of variation).

Main Results:

• The developed RIA demonstrated high specificity for sulprostone, with cross-reactivity <0.1% against related prostaglandins (PGE2, PGF2 alpha) and metabolites.
• The assay's routine measurement range was 10-300 pg of sulprostone, equivalent to 50-1500 pg/ml of plasma.
• Replicate analyses showed a coefficient of variation of 8-12%, indicating good precision.

Conclusions:

• A sensitive and specific radioimmunoassay for sulprostone has been successfully developed.
• The assay is suitable for measuring subnanogram quantities of sulprostone in human plasma.
• This validated RIA can be utilized to determine sulprostone pharmacokinetics in clinical settings.